Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been retracted at the request of the Editor-in-Chief.An Expression of Concern for this article was previously published while an investigation was conducted (see related editorial: https://doi.org/10.1016/j.biopha.2022.113812). This retraction notice supersedes the Expression of Concern published earlier.Concern was raised about the reliability of the images in Figure 5B, and the Western blots shown in Figure 9A+B, which appear to contain similar repeated features, and a phenotype found in other publications, as detailed here: https://pubpeer.com/publications/81D7B72D646EC532D0DFF63338A55F; and here: https://docs.google.com/spreadsheets/d/1r0MyIYpagBc58BRF9c3luWNlCX8VUvUuPyYYXzxWvgY/edit#gid=262337249. Independent analysis confirmed these findings and identified additional suspected image duplications in Figures 5A+B and 9A+B. The journal requested the corresponding author comment on these concerns and provide the associated raw data. The authors did not respond to this request and therefore the Editor-in-Chief decided to retract the article.

Retraction Notice To: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.

Retraction Notice To: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

Retraction Notice to: MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer

Retraction Notice To: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing P53-Mediated Mir-205-5p Expression.

Retracted: WNT974 Inhibits Proliferation, Induces Apoptosis, and Enhances Chemosensitivity to Doxorubicin in Lymphoma Cells by Inhibiting Wnt/b-Catenin Signaling

Retraction Note To: Inhibition of ZEB1-AS1 Confers Cisplatin Sensitivity in Breast Cancer by Promoting Microrna-129-5p-dependent ZEB1 Downregulation

Retraction Notice to “Microrna-27A Regulates the Proliferation, Chemosensitivity and Invasion of Human Ovarian Cancer Cell Lines by Targeting Cullin 5” [YABBI 688C (2019) 9–15 / 7995]

Retraction Note: Long Non-Coding RNA LINC00968 Attenuates Drug Resistance of Breast Cancer Cells Through Inhibiting the Wnt2/β-catenin Signaling Pathway by Regulating WNT2

Retraction Notice to: Exosome miR-155 Derived from Gastric Carcinoma Promotes Angiogenesis by Targeting the c-MYB/VEGF Axis of Endothelial Cells

Retraction Notice To: Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer

Retraction Note: Exosome-transmitted Mir-128-3p Increase Chemosensitivity of Oxaliplatin-Resistant Colorectal Cancer

[Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway

Retraction Note: Microrna-140-5p Inhibits Colorectal Cancer Invasion and Metastasis by Targeting ADAMTS5 and IGFBP5

RETRACTED: the Effects of the Long Non-Coding RNA MALAT-1 Regulated Autophagy-Related Signaling Pathway on Chemotherapy Resistance in Diffuse Large B-cell Lymphoma

Retraction Notice To: Mir-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10

Retraction Note To: the Circrna Circagfg1 Acts As a Sponge of Mir-195-5p to Promote Triple-Negative Breast Cancer Progression Through Regulating CCNE1 Expression

Retraction notice to "A DNA-based nanocarrier for efficient cancer therapy" [J. Pharm. Anal. 11 (2021) 330-339]

Retracted: Analysis of Molecular Mechanism of YiqiChutan Formula Regulating DLL4-Notch Signaling to Inhibit Angiogenesis in Lung Cancer

Antitumor Effects of Helenalin in Doxorubicin-Resistant Leukemia Cells Are Mediated Via Mitochondrial Mediated Apoptosis, Loss of Mitochondrial Membrane Potential, Inhibition of Cell Migration and Invasion and Downregulation of PI3-kinase/AKT/m-TOR Signalling Pathway.

Reduced Mir-363-3p Expression in Non-Small Cell Lung Cancer is Associated with Gemcitabine Resistance Via Targeting of CUL4A.